ArticleCell death & disease2023

RPL22L1, a novel candidate oncogene promotes temozolomide resistance by activating STAT3 in glioblastoma.

Yunping Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.